- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.19: 3 residues within 4Å:- Chain A: S.112, N.164, N.165
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: T.108, N.234
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: Y.28, S.60, N.61
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: N.280, N.282
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain A: N.603
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain A: N.616
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain A: H.655, N.657
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.164, N.165
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: E.465
- Chain B: T.108, N.234
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain B: Y.28, N.30, N.61
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.282
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.603
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain B: N.616, T.618, Q.644
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.657
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain B: N.709, G.1131
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: N.164, N.165
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: T.108, N.234
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.61
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: K.558
- Chain C: N.280, N.282
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.331, Q.580
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain C: N.603
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.616, T.618
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: H.655, N.657
Ligand excluded by PLIPNAG.47: 4 residues within 4Å:- Chain A: D.796
- Chain C: N.709, I.1130, G.1131
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: A.706, E.1072, K.1073, N.1074
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guo, H. et al., Structures of Omicron spike complexes and implications for neutralizing antibody development. Cell Rep (2022)
- Release Date
- 2022-06-01
- Peptides
- Spike glycoprotein: ABC
510A5 light chain: DFH
510A5 heavy chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
I
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Guo, H. et al., Structures of Omicron spike complexes and implications for neutralizing antibody development. Cell Rep (2022)
- Release Date
- 2022-06-01
- Peptides
- Spike glycoprotein: ABC
510A5 light chain: DFH
510A5 heavy chain: EGI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FH
HE
EG
GI
I